Dr. Lisa Chapa Explains Why Not Every Breast Lump Is Cancer

Breast surgeon discusses early detection, diagnostic testing and treatment options for benign breast conditions during McAllen symposium

Translate to Spanish or other 102 languages!

Dr. Lisa Chapa, breast surgeon, delivers her presentation, “Benign Breast Disease: Work Up, Diagnosis, & Treatment,” during the October 16, 2026, breast cancer symposium in McAllen, Texas. Chapa explains the importance of proper evaluation, early diagnosis, and appropriate treatment of noncancerous breast conditions, emphasizing that not every breast lump is cancer. Photo by Mega Doctor News.
Dr. Lisa Chapa, breast surgeon, delivers her presentation, “Benign Breast Disease: Work Up, Diagnosis, & Treatment,” during the October 16, 2026, breast cancer symposium in McAllen, Texas. Chapa explains the importance of proper evaluation, early diagnosis, and appropriate treatment of noncancerous breast conditions, emphasizing that not every breast lump is cancer. Photo by Mega Doctor News.
- Advertisement -

By Roberto Hugo González / Mega Doctor News

McALLEN, Texas — Discovering a lump in the breast can cause immediate concern, but many breast abnormalities are not cancerous, according to Dr. Lisa Chapa, a breast surgeon who explained how physicians distinguish benign conditions from breast cancer.

Chapa presented “Benign Breast Disease: Work Up, Diagnosis, & Treatment” on October 16, 2026, during the symposium “Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership.”

- Advertisement -

“Benign breast disease is way more common than cancer is,” Chapa told attendees, emphasizing that a physical examination alone cannot reliably distinguish a harmless lump from a cancerous one.

“If you feel a lump or if you feel a mass in your breast, one, don’t panic, but two, get it checked out,” she said.

Chapa explained that mammograms, ultrasounds and biopsies help physicians determine whether an abnormality requires treatment.

She discussed breast cancer screening recommendations from the American Society of Breast Surgeons, including formal risk assessments beginning at age 25 and annual mammograms starting at age 40 for women at average risk.

- Advertisement -

Women with higher risk may need earlier screening and additional imaging, she said.

Chapa also explained the Breast Imaging Reporting and Data System, known as BI-RADS, which radiologists use to classify findings.

Categories 1 and 2 generally indicate negative or benign findings. Category 3 means an abnormality is probably benign and typically requires follow-up imaging after six months. Categories 4 and 5 indicate suspicious findings that generally require a biopsy.

One common benign condition is fibroadenoma, a solid breast lump frequently diagnosed in women younger than 30.

Chapa said fibroadenomas usually do not require surgery unless they grow rapidly, become unusually large or cause visible changes to the breast.

However, some noncancerous abnormalities require closer attention.

She discussed atypical ductal hyperplasia, a condition involving abnormal cell growth inside breast ducts.

Although it is not cancer, Chapa said surgical removal may reveal cancer in approximately 30% of cases initially diagnosed through needle biopsy.

She also discussed intraductal papillomas, growths inside breast ducts that may cause nipple discharge.

Papillomas without atypical cells can often be monitored, while those containing atypical cells may require surgery because of their association with cancer.

Another condition, lobular carcinoma in situ, is not considered invasive breast cancer but indicates an increased lifetime risk of developing the disease, Chapa explained.

Chapa addressed breast infections, including mastitis, and warned that inflammatory breast cancer can resemble an infection.

She advised further evaluation when breast redness, swelling, and other symptoms do not improve with antibiotic treatment.

The surgeon also stressed the importance of reviewing imaging and biopsy results together.

A benign biopsy does not always settle the diagnosis if the pathology findings fail to explain a suspicious mammogram.

“If it’s discordant, you gotta go to surgery,” Chapa said, referring to cases in which imaging and pathology findings do not agree.

Her central message was that benign breast conditions are common, but accurate diagnosis and appropriate follow-up remain essential.

See related stories:

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How to Keep Your Thanksgiving Dinner Safe

As families across the country prepare for Thanksgiving, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is reminding consumers to take simple steps that will keep their holiday meals safe and enjoyable.

Op-ED: More than a ‘Smokers Disease’: Why Lung Cancer Awareness Must Become a Priority

In the wake of Pope Leo XIV’s recent lung cancer diagnosis, public interest in the disease has surged, underscoring the important role prevention and early detection play in achieving better outcomes.

How Friday the 13th Became the Most Feared Date on the Calendar

Today is Friday, but not everyone is celebrating the end of the workweek this time around. That’s because of superstition surrounding Friday the 13th.

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.
- Advertisement -